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syndrome.3	 More	 recently,	 the	 role	 of	 galectin-	3	 and	 galectin-	3	
binding	protein	in	venous	thrombosis	was	identified	by	DeRoo	et	al.	






in	 venous	 thromboembolism,	 the	work	of	Fashanu	et	al.1	 provides	





900,000	Americans	will	develop	DVT	every year with the affected 
population	 expected	 to	 double	 by	 2050.5	 Moreover,	 the	 cost	 of	
post-	thrombotic	syndrome,	a	long-	term	complication	of	DVT,	is	ap-
proximately	3	billion	dollars	per	year	in	the	US.6	Why	is	post	throm-





















data,	 as	was	done	 in	Fashanu	et	al.,	will	 lead	 to	much	needed	 im-
provements	for	all	those	suffering	from	venous	thromboembolism.	
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